Form 4 for OSCR Oscar Health, Inc.
Accepted 2026-03-04 00:00:00 ET · period of report 2026-03-02 · accession 0001568651-26-000026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | 2026-03-02 | OSCR | Bertolini Mark T | CEO, Dir | A - Grant | $0.00 | +1.60M | 4.46M | +56% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-03-02 | A | A | 1,596,877 | $0.00 | 4,463,543 | D | — | — | (F1) The shares represent restricted stock units, which will vest in three equal annual installments beginning on March 2, 2027, subject to the Reporting Person's continued employment or service as the Chief Executive Officer or as a member of the Board of Directors through the applicable vesting date. (F2) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |